Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 20 studies | 31% ± 15% | |
pericyte | 13 studies | 33% ± 13% | |
retinal bipolar neuron | 5 studies | 27% ± 5% | |
myofibroblast cell | 5 studies | 33% ± 10% | |
OFF-bipolar cell | 4 studies | 27% ± 7% | |
fibroblast | 4 studies | 30% ± 17% | |
oligodendrocyte precursor cell | 4 studies | 31% ± 10% | |
ON-bipolar cell | 3 studies | 30% ± 9% |
Insufficient scRNA-seq data for expression of WFDC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 5124.84 | 242 / 245 | 99% | 13.56 | 497 / 502 |
intestine | 95% | 3294.00 | 920 / 966 | 90% | 3.91 | 474 / 527 |
bladder | 100% | 3531.57 | 21 / 21 | 83% | 3.97 | 419 / 504 |
stomach | 87% | 1151.30 | 311 / 359 | 90% | 4.46 | 257 / 286 |
adrenal gland | 98% | 1730.05 | 254 / 258 | 74% | 3.82 | 170 / 230 |
kidney | 96% | 967.83 | 85 / 89 | 67% | 2.96 | 606 / 901 |
lung | 99% | 1999.13 | 575 / 578 | 57% | 1.68 | 663 / 1155 |
brain | 90% | 733.10 | 2379 / 2642 | 64% | 2.41 | 454 / 705 |
esophagus | 75% | 1081.38 | 1087 / 1445 | 73% | 2.35 | 133 / 183 |
uterus | 59% | 773.29 | 101 / 170 | 59% | 3.10 | 272 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.34 | 1 / 1 |
blood vessel | 98% | 4459.20 | 1307 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 20.08 | 74 / 80 |
pancreas | 1% | 2.95 | 3 / 328 | 72% | 2.35 | 129 / 178 |
thymus | 47% | 275.03 | 310 / 653 | 25% | 0.43 | 152 / 605 |
breast | 32% | 213.00 | 147 / 459 | 33% | 0.90 | 373 / 1118 |
skin | 18% | 89.02 | 321 / 1809 | 42% | 10.53 | 197 / 472 |
ovary | 16% | 190.39 | 28 / 180 | 33% | 0.96 | 142 / 430 |
liver | 22% | 106.80 | 50 / 226 | 20% | 0.44 | 83 / 406 |
adipose | 35% | 266.99 | 418 / 1204 | 0% | 0 | 0 / 0 |
spleen | 28% | 116.12 | 67 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.20 | 5 / 45 |
heart | 9% | 40.46 | 74 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 12.64 | 23 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 8.27 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0001558 | Biological process | regulation of cell growth |
GO_0061045 | Biological process | negative regulation of wound healing |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005615 | Cellular component | extracellular space |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0003674 | Molecular function | molecular_function |
Gene name | WFDC1 |
Protein name | WAP four-disulfide core domain protein 1 (Prostate stromal protein ps20) (ps20 growth inhibitor) WAP four-disulfide core domain 1 |
Synonyms | PS20 |
Description | FUNCTION: Has growth inhibitory activity. . |
Accessions | A0A087WY77 Q9HC57 ENST00000219454.10 ENST00000568638.1 ENST00000613603.1 |